Fuzzy linguistic model for evaluating the risk of neonatal death

Autor: Nascimento Luiz Fernando C, Ortega Neli Regina S

Publikováno v: Revista de Saúde Pública, Vol 36, Iss 6, Pp 686-692 (2002)

OBJECTIVE: To introduce a fuzzy linguistic model for evaluating the risk of neonatal death. METHODS: The study is based on the fuzziness of the variables newborn birth weight and gestational age at delivery. The inference used was Mamdani's method. N

Externí odkaz: https://doaj.org/article/ccc3888343c148888c069d442b726ba6

Decreased functional connectivity is associated with increased levels of Cerebral Spinal Fluid soluble-PDGFRβ, a marker of blood brain barrier breakdown, in older adults.

Autor: Contreras JA; Department of Neurosciences, Alzheimer's Disease Cooperative Study (ADCS), University of California, San Diego, CA, USA., Fujisaki K; Mark and Mary Stevens Neuroimaging and Informatics Institute, University of Southern California, Los Angeles, CA, USA., Ortega NE; Department of Neurosciences, Alzheimer's Disease Cooperative Study (ADCS), University of California, San Diego, CA, USA., Barisano G; Department of Physiology and Neuroscience, Zilkha Neurogenetic Institute, University of Southern California, Los Angeles, CA, USA., Sagare A; Department of Physiology and Neuroscience, Zilkha Neurogenetic Institute, University of Southern California, Los Angeles, CA, USA., Pappas I; Mark and Mary Stevens Neuroimaging and Informatics Institute, University of Southern California, Los Angeles, CA, USA., Chui H; Department of Neurology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Ringman JM; Department of Neurology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Joe EB; Department of Neurology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Zlokovic BV; Department of Physiology and Neuroscience, Zilkha Neurogenetic Institute, University of Southern California, Los Angeles, CA, USA., Toga AW; Mark and Mary Stevens Neuroimaging and Informatics Institute, University of Southern California, Los Angeles, CA, USA., Pa J; Department of Neurosciences, Alzheimer's Disease Cooperative Study (ADCS), University of California, San Diego, CA, USA. jpa@ucsd.edu.

Publikováno v: Brain imaging and behavior [Brain Imaging Behav] 2024 Sep 10. Date of Electronic Publication: 2024 Sep 10.

Modeling ability to resist alcohol in the human laboratory: A pilot study.

Autor: Sloan ME; Addictions Division, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.; Division of Neurosciences and Clinical Translation, Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.; Department of Pharmacology & Toxicology, University of Toronto, Toronto, Ontario, Canada.; Department of Psychological Clinical Science, University of Toronto Scarborough, Toronto, Ontario, Canada.; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada., Sells JR; Department of Medical and Clinical Psychology, Uniformed Services University of Health Science, USA.; Human Psychopharmacology Laboratory, National Institute on Alcohol Abuse and Alcoholism, 10 Center Drive, Rm 2-2352, Bethesda, MD 20892, USA., Vaughan CL; Department of Medical and Clinical Psychology, Uniformed Services University of Health Science, USA.; Human Psychopharmacology Laboratory, National Institute on Alcohol Abuse and Alcoholism, 10 Center Drive, Rm 2-2352, Bethesda, MD 20892, USA., Morris JK; Human Psychopharmacology Laboratory, National Institute on Alcohol Abuse and Alcoholism, 10 Center Drive, Rm 2-2352, Bethesda, MD 20892, USA., Ortega NE; Human Psychopharmacology Laboratory, National Institute on Alcohol Abuse and Alcoholism, 10 Center Drive, Rm 2-2352, Bethesda, MD 20892, USA., Sundar S; Human Psychopharmacology Laboratory, National Institute on Alcohol Abuse and Alcoholism, 10 Center Drive, Rm 2-2352, Bethesda, MD 20892, USA., Soundararajan S; Human Psychopharmacology Laboratory, National Institute on Alcohol Abuse and Alcoholism, 10 Center Drive, Rm 2-2352, Bethesda, MD 20892, USA., Stangl BL; Human Psychopharmacology Laboratory, National Institute on Alcohol Abuse and Alcoholism, 10 Center Drive, Rm 2-2352, Bethesda, MD 20892, USA., Gowin J; Human Psychopharmacology Laboratory, National Institute on Alcohol Abuse and Alcoholism, 10 Center Drive, Rm 2-2352, Bethesda, MD 20892, USA.; Department of Radiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Chawla S; Human Psychopharmacology Laboratory, National Institute on Alcohol Abuse and Alcoholism, 10 Center Drive, Rm 2-2352, Bethesda, MD 20892, USA., Diazgranados N; Office of the Clinical Director, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD, USA., McKee SA; Yale University, New Haven, CT, USA., Waters A; Department of Medical and Clinical Psychology, Uniformed Services University of Health Science, USA., Ramchandani VA; Human Psychopharmacology Laboratory, National Institute on Alcohol Abuse and Alcoholism, 10 Center Drive, Rm 2-2352, Bethesda, MD 20892, USA.

Publikováno v: Drug and alcohol dependence reports [Drug Alcohol Depend Rep] 2022 Oct 07; Vol. 5, pp. 100105. Date of Electronic Publication: 2022 Oct 07 (Print Publication: 2022).